THE TGA has issued a recall order
for Aspen Pharma’s Serenace 0.5mg
tablets (containing haloperidol)
batch number BJ431.
The recall is being conducted
because the manufacturer has
received reports of tablets from
the affected batch with black spots
identified as penicillium species.
The order has been classified as
Class I meaning that the defects
are potentially life-threatening or
could cause a serious risk to health.
Patients are being advised not to
use the affected batch, but to
return it to their local pharmacy
and arrange for a replacement.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Sep 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Sep 12
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.